Brevan Howard Capital Management’s Globus Medical GMED Stock Holding History

Brevan Howard Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.55M	Buy	19,565 +15,395	+369%	+$1.31M	0.01%	845
2026 Q1	$359K	Sell	4,170 -22,415	-84%	-$2.01M	﹤0.01%	1502
2025 Q4	$2.32M	Buy	26,585 +20,922	+369%	+$1.59M	0.03%	444
2025 Q3	$324K	Sell	5,663 -3,608	-39%	-$208K	﹤0.01%	1529
2025 Q2	$547K	Buy	+9,271	New	+$599K	﹤0.01%	1319
2024 Q4	–	Sell	-6,252	Closed	-$447K	–	1197
2024 Q3	$447K	Sell	6,252 -604	-9%	-$42.6K	﹤0.01%	715
2024 Q2	$470K	Buy	+6,856	New	+$410K	﹤0.01%	631

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Brevan Howard Capital Management's GMED Position: Q2 2026 in Review

Brevan Howard Capital Management increased its Globus Medical (GMED) stake by 369% in Q2 2026, buying an estimated $1.31M and bringing the position to 19,565 shares worth $1.55M. The position accounts for 0.01% of the portfolio, ranked #845.

Brevan Howard Capital Management first reported a position in GMED in Q2 2024 and has held it in 7 quarters since. The position peaked at $2.32M in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Brevan Howard Capital Management held 19,565 shares of Globus Medical worth $1.55M as of Q2 2026.
Brevan Howard Capital Management bought 15,395 Globus Medical shares in Q2 2026, an estimated $1.31M.
Globus Medical made up 0.01% of Brevan Howard Capital Management's portfolio in Q2 2026, its #845 holding.
Brevan Howard Capital Management first reported a position in Globus Medical in Q2 2024 and has held it in 7 quarters since.
Brevan Howard Capital Management's Globus Medical position peaked at $2.32M in Q4 2025.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.